6533b81ffe1ef96bd1278644

RESEARCH PRODUCT

Research update for articles published in EJCI in 2016

Christopher AdlbrechtAlejandro Blanco-vereaMaría C. Bouzas-mosqueraMaría BrionMartin BurtscherFederico CarboneTing-ting ChangEvangelia CharmandariJaw-wen ChenLiane Correia-costaRobin P. F. DullaartMakarios EleftheriadesBeatriz Fernandez-fernandezGeorg GoliaschThomas GremmelMenno Evert GroeneveldAlexandrino HenriqueMartin HuelsmannChristian JungMichael LichtenauerFabrizio MontecuccoNicolas C. NicolaidesAlexander NiessnerCarlos PalmeiraMarkus PirklbauerMaria Dolores Sanchez-niñoAlexandros SotiriadisTeresa SousaPatrick SulzgruberAndré P. Van BeekNicola VeroneseMax-paul WinterKak Khee YeungAlberto Bouzas-mosquera

subject

ABDOMINAL AORTIC-ANEURYSMGENERAL-POPULATIONADVANCED HEART-FAILURE2016Clinical BiochemistryEJCIBLOOD-PRESSUREDIABETES-MELLITUSGeneral MedicineBiochemistryMaratónTratamiento médicoMYOCARDIAL-INFARCTIONCARDIOVASCULAR-DISEASEAtletaHipertensiónCORONARY-ARTERY-DISEASEEcocardiografíaBONE-MINERAL DENSITYENDOTHELIN RECEPTOR BLOCKADESistema cardiovascular

description

The association of an excessive blood pressure increase with exercise (i.e., an increase in systolic blood pressure with exercise ≥95th percentile) with lower risk of subsequent events in patients with known or suspected coronary artery disease has been consistently verified even in those with baseline hypertension. Nonetheless, this negative association, also confirmed in another study on a Japanese population, might depend on peak VO2, such that the prognostic value of blood pressure response might be limited in patients with preserved exercise capacity. In addition, a hypertensive response with exercise (defined as a systolic blood pressure ≥220 mmHg during the test) has also been associated with lower risk of echocardiographic myocardial ischemia. These findings might be mediated mainly by the degree of exercise-induced increase in cardiac output, which is a main determinant of blerved.ood pressure response and may be blunted or even reversed in the presence of significant coronary artery disease. Sin financiación 2.784 JCR (2018) Q1, 37/160 Medicine, General & Internal; Q2, 67/136 Medicine, Research & Experimental 1.097 SJR (2018) Q1, 470/2844 Medicine (miscellaneous), 27/133 Clinical Biochemistry; Q2, 140/462 Biochemistry No data IDR 2018 UEM

10.1111/eci.13016http://hdl.handle.net/10447/457887